Research and Markets: Remifentanil - Key patent, SPC, and data exclusivity ... Business Wire (press release) The 'Key Patent Indicator' section is intended to provide an indication of the Key Patents pertaining to a generic drug, and is not based on a comprehensive patent search (a comprehensive patent search can be found in the corresponding Pipeline ... |
Thursday, March 24, 2011
Research and Markets: Remifentanil - Key patent, SPC, and data exclusivity ... - Business Wire (press release)
http://sootheze.com/toasty-collar-collection.php
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment